# Morari, Inc.

Climax Control Patch for a MOR Intimate Experience

## Elevator pitch
Morari has developed a chemical-free wearable skin patch for the treatment of premature ejaculation (PE). PE is the most prevalent male sexual dysfunction, estimated to affect 30% of men worldwide.

- Canonical URL: https://wefunder.com/morari.inc
- Entity ID: wefunder:company:119667
- Last updated: 2026-06-11T05:00:46Z
- Generated at: 2026-06-12T04:02:59Z

## Quick facts
- FDA Cleared! First significant innovation in the male sexual health industry since Viagra!
- A unique, patented product in a $37B global sexual health and wellness market.
- Revenue projected to reach over $15M by the end of 2027 (not guaranteed).
- Winner of Proctor & Gamble Innovation Challenge and many other awards.
- Global media buzz includes: Daily Mail, CNET, Men’s Health, Forbes, and the Jimmy Kimmel Live show.
- Over 75 years of collective experience in urology, sexual health, medical device product launch.

## Active fundraises
- wefunder:fundraise:120232: 4(a)(6) successful (USD)
- wefunder:fundraise:120231: 4(a)(6) successful (USD)
- wefunder:fundraise:74661: 506(c) successful (USD)
- wefunder:fundraise:66932: 4(a)(6) successful (USD)
- wefunder:fundraise:66933: 4(a)(6) successful (USD)

## Story
MOR is a drug-free wearable skin patch to help enhance or improve sexual performance. You’re not alone! An estimated 30% of men experience challenges with early climax, while another 40% of men would simply like to last longer to improve partner satisfaction.At Morari, we are tackling this problem head-on with the groundbreaking MOR patch.This is pioneering innovation in the massive male sexual wellness market, which has had no significant innovation for over 20 years. Hear what Jimmy Kimmel had to say about MOR:MOR requires no drugs, no numbing or desensitizing creams, no painful procedures, and no prescriptions – just intense pleasure controlled with the ease and convenience of a smartphone app.The Science Behind MOR.The MOR System features a wearable skin patch that includes a wireless transcutaneous electric nerve stimulator (TENS), a Bluetooth transmitter, and a small battery. The patch is worn during intercourse on the skin in the perineum (between the scrotum and anus). When the time is right, the patch is applied and activated via a simple smartphone app, where users can customize the settings to find their sweet spot. Once on, a quiet and gentle sensation is temporarily felt that confuses the nerves responsible for carrying the signals from the penis to the brain, and those from the brain to the muscles that cause contraction and ejaculation.It’s safe, it’s comfortable, and most importantly, gives you control! MOR has been reported to not only delaying a climax, but also intensifying it. When Viagra hit the market in 1998, the little blue pill earned Pfizer $400 million within three months of its launch.  It went on to generate billions of dollars of sales over the following two decades.Today, Morari has the unique opportunity to spice thigs up in a $37B global sexual health and wellness market.POTENTIAL CUSTOMER BASE OF OVER 1 BILLION MENEarly ejaculation is very prevalent among men. These men – and their partners – suffer in silence. For them, this sensitive problem can be a source of major disappointment and shame which is often kept private and seldom talked about - even with medical professionals - impacting self-esteem and relationships.POTENTIAL APPEAL TO PARTNERSPartners are also significantly impacted by early ejaculation as they can be left disappointed, frustrated, and dissatisfied with their sexual relationship. This delicate issue can lead to a breakdown of intimacy and communication as couples struggle to manage the impact on their bond.It’s no wonder that the current annual consumption for ejaculation delay-related products, including sprays, creams, and drug therapies, is currently greater than $1 billion! Even with all that money on the table, none of the current treatments have significantly resolved the issue and some negative side effects often outweigh their positive. Our closest direct competitor, in2, is a single-use product and lacks an app for customized settings. MOR simply has more to offer.Clearly, the demand is there for couples around the world in need of MOR. And it can’t come too soon.READY TO GET BUSYWe are ready to take things to the next level – let’s get busy.As part of our discovery process, we conducted early feasibility and usability studies and the results were a success, validating our patch.The toe-curling testimonials are further validating! We expect our FDA clearance in Q1, 2025, clearing the path for getting MOR into the hands (and pants) of the public.Future projections are not guaranteedWE HAVE ALREADY GONE VIRAL!Even before the official product launch, MOR has created a considerable buzz around the world. The global interest in our solution gives us continued confidence in our mission to provide an answer to an unmet need that exists for men worldwide. This also underscores the opportunity to develop and execute a comprehensive sales and marketing campaign.Morari has been featured in: and many others...Go here for our media page.This coverage brought in millions of hits on our website with 4,000+ potential customers signing up to be kept informed on launch progress. The amazing feedback and support we received demonstrated the urgency in this market.We were also featured on ABC’s Jimmy Kimmel Live! - a show with an average of 1.8 million viewers. INNOVATION RECOGNIZED IN INDUSTRYThe MOR patch has not yet hit the market, but our innovation has already been recognized across the industry with the following awards and honors:And this is just the beginning!LAUNCH PLAN READY AND WAITINGWe have engaged an experienced direct-to-consumer external marketing firm which will provide us with a detailed launch plan to reach our target market.During the first phase of commercialization, we will sell our product via a direct-to-consumer model through a dedicated online store and established online distributors.The second phase will target distribution through existing retailers.CLEAR ROADMAP TO FUTURE EXITFor something intended to slow things down in the bedroom, MOR has the potential to generate a quick path to profit.We expect to be net income positive less than 24 months after launch!Our revenue and net income projections currently stand at: Our planned exit strategy is an acquisition. Based on the results of the product launch, we will initiate discussions with potential acquirers about interest in Morari. DRIVEN BY A WORLD-CLASS TEAMYour investment is in great hands. We are equipped with a team of experts, leveraging 75 years of collective experience in urology and sexual health.Our team is led by CEO and founder Jeff Bennett, who has more than 25 years of medical device experience. He has also led the global launch of several high-profile products.INVEST IN THE FUTURE OF CLIMAX CONTROL TODAYThis is your opportunity to invest in a company with incredible potential to make a real impact in the growing industry. This is also the last chance to lock in an investment under pre-FDA clearance terms!We are opening our doors to the Wefunder community for a 2nd time to launch MOR. We previously raised over $652,000 on Wefunder and we know we can do it again.The proceeds of this community round will be used to execute the commercial launch, purchase inventory, make key hires in commercial and operations departments, develop our e-commerce site, and software maintenance.We think MOR could become the biggest thing in the growing male sexual product industry since Viagra – and this is your chance to come along for the ride.Invest in Morari today! NON-MARKETING DISCLAIMERMorari has not received regulatory clearance to market MOR. The funds from this campaign will support the submission requesting regulatory clearance and preparing for commercialization when approved. An investment is not a purchase of the MOR product. No product, of any kind, will be provided in connection with an investment in this fundraising campaign.

## FAQ
1. **Great idea but I can't see men choosing to wear this, and then having to use it from the phone first? I think it would be equally embarrassing for men to wear it. Can I hear your thoughts?**
   - Our initial target market are couples in committed relationships who wish to delay ejaculation. Our research suggests a strong interest in men wanting to try a wearable patch. In a recent survey of 40 men, 40/40 indicated they were very interested or extremely interested when asked the question "How interested are you in trying the Mor Time wearable patch?" We have also performed comfort and fit studies of the patch with positive ratings. Having a mobile app available via a smartphone gives t...
2. **I have a few more questions please if you could respond, I have read form C, Who owns the patents? What is the 13.5% compensation used for exactly? Will you provide a liquidity event to convert preferred shares to common? Are you offering participating liquidation preferences?...**
   - Morari Medical owns all current patent filings. The 13.5% of compensation will be used to compensate CEO, finance, commercialization, operations and R&D leaders. There is no liquidity event that mandates the conversion of preferred shares to common. However, upon a “Deemed Liquidation Event” (as defined in our current charter), holders of Preferred Stock will be paid the greater of the Original Issue Price per share of preferred stock OR such amount per share as would be payable if all sh...
3. **How would you rate your competition with such as Virility Medical and others?**
   - There have been multiple attempts to treat premature ejaculation (PE) through a variety of methods to include physiological/behavioral counseling, drug treatment, topical local anesthetics, cryoablation and radio frequency. To date there is no chemical-free wearable product option available to consumers. We are aware of Virility Medical and look forward to another company helping to drive awareness of PE. We believe we will have an overall superior user experience.
4. **Virility already have the same product as yours? Why is yours unique?**
   - We are aware of Virility Medical and look forward to another company helping to drive awareness of PE. We believe we will have an overall superior user experience.
5. **What is the regulatory pathway? Have u confirmed that it would be a class I ? Will be it allowed to be a 510k? Thanks**
   - Our patch would be considered a class II device and would be considered a 510k submission. We had a very positive pre-sub meeting with the FDA earlier this year. We have a clear path to FDA clearance and know what testing and data is needed for submission.

## Team
- Jeff Bennett (CEO and Founder)
- Dr. Jane Guyn (Sexologist)
- Toni Dandrea (Commercialization Advisor)
- Michael Hoey, PhD (Scientific Advisor)
- Mark Payne (Chief Financial Officer)
- Sew-Wah Tay, PhD (Regualtory/Clinical/Quality Advisor)

## Recent posts
- MOR Holiday Offer (2025-12-13T21:31:08Z)
- Thank you again for believing in Morari and supporting us through our Wefunder raise. Because of you, MOR is now FDA-cleared and in the hands of real users. A special thanks to those who have already ordered and tried MOR, your feedback has been invaluable.MOR was designed to support men’s sexual health by improving pleasure, confidence, and intimacy.We’re excited to share that early experience with MOR has been encouraging, and we’re now preparing to expand access.As a thank-you, we’re offer... (2025-12-13T18:49:52Z)
- Join Our Ejaculation Intensity Study and Save 25% (2025-08-04T13:15:45Z)
- 📱BIG NEWS - MOR App Now Available for Android Phones (2025-08-01T14:17:34Z)
- Unlock MOR with the MOR App – and Get Free Shipping (2025-07-22T16:32:53Z)
- What's Your MOR? (2025-07-13T13:08:06Z)
- Community launch: Groove Thing, a new music & pleasure product (2025-07-11T14:26:36Z)
- MOR - Shipped Discreetly. Delivered Confidently. (2025-07-10T15:32:40Z)
- MOR Pilot Progress + Early Access Offer for Wefunder Investors (2025-07-07T13:43:29Z)
- MOR inventory! (2025-07-02T21:38:10Z)
- Wefunder MOR Starter Kit offer: 20% off plus free shipping (2025-06-24T20:11:04Z)
- Closing Today! Last Chance. (2025-04-17T16:01:03Z)
- Meet the Investor: Dr. Elliot Justin, Founder & CEO of FirmTech (2025-04-16T18:22:31Z)
- Big News: MOR App Approved by Apple! (2025-04-14T01:22:13Z)
- Why Invest in Morari? (2025-03-30T13:14:05Z)

## Q&A
- Q: Have you taken subscription into consideration?? The world is moving to the subscription space with every innovation now. Subscription has the potential of generating more revenue and reward for the company and shareholders, for the long term, than acquisition
  - A: Thanks for the question. Yes we have thought about a subscription model for the reasons you mention. More details on this will be made available as we get closer to launch.
- Q: Patented? Similar competition? What is level of VC interest of any? Who? Thanks again.
  - A: To date, we have been issued 1 patent on different methods and product designs to delay an ejaculation. We have several other patents filed and are awaiting for additional patents to be issued. We are aware of another company based in Israel called Virility Medical who working on similar approach. We have had several VCs express interest in what we are working on and have encouraged us to get back to them once we have achieved FDA clearance and have initial revenue traction. We have been fortunate to raise the necessary funds to date through friends/family/angel investors/family office/crowdfunding. Upon FDA clearance and revenue generation, we expect the valuation of the company to increase.
- Q: 1. FDA approval is not easy and it is a long process. What experiences and resources are you using to seek approval? What is timeframe and likelihood of approval? 2. What sales volume/ valuation are you looking to be at before you sell company? 3. If FDA approved, is there a health insurance market for this product? 4. Does it stay on or hurt to remove after use? Thanks.
  - A: Jeremy, Our patch would be considered a class II device and will need a 510k submission. We had a very positive pre-sub meeting with the FDA earlier this year. We have a clear path to FDA clearance and know what testing and data is needed for submission. We expect to have FDA clearance and a commercial product in the second half of 2023. Once we have launched the product and proven product sales traction, we will have discussions with potential exit partners. The timing of an exit is very difficult to predict. We expect that our product will be an out-of-pocket expense for our customers. While there is a scenario where we could get insurance coverage, it's something that would need a study to determine the cost-benefit of our product vs. other products being used. This is not in our immediate plans but something we will revisit once we have launched out first product. During a feasibility study we gathered feedback on the comfort and fit of wearing the patch. On a scale from 1 - 10 with 1 being very difficult or very uncomfortable and 10 being very easy or very comfortable, ratings were at least a 7 in terms of comfort and fit of the patch when excess hair was removed for the target placement of the patch.
- Q: Hello Mr. Bennett, First of all I'd like to congratulate you and the Morari team for accomplishing this great milestone of becoming FDA approved. So many men like myself will benefit from your product and will have a greater opportunity to please their wives and even potentially save their marriages. I invested over $1000 in the project as soon as I read about it a few years ago. And I've been waiting impatiently for it to finally be available for purchase. I have a very terrible case of premature ejaculation. I ejaculate with 15 to 20 seconds of sexual intercourse. This problem has had a serious strain on my marriage to the point that I always have to promise my wife that I will last a little longer in the second round. I can't wait to finally see the day when my wife climaxes before me. And I know that your product will be the reason for me attaining this great achievement.  You may not remember, but I previously wrote to you requesting to be one of your testers of the product. I was hoping that at least the beta version would help me last a little longer. Unfortunately, you didn't need any more testers. Now that the product has been FDA approved and I'm assuming it's in the process of mass production, I was wondering if you could do me a huge favor and allow me to purchase the product early before it is officially made accessible to the public. I'm not sure how long it will take to get to the market but I'm just so anxious to try it out. I've been waiting so long for it and I check my email every month for any updates. That's why I had to write to you after you sent out the good news yesterday. The fact that it's now FDA approved means that all possible concerns could now be put to rest. Using the product now will be the same as using it when it's made available to the public.  If you could please send me a link where I could pay the cost of the product and then ship it to me, I would be soooo grateful for this huge favor. I would be honored to be your first paid customer, who's also an investor in your vision and great effort of helping millions of men deal with and get over their problem of premature ejaculation. I pray that you make an exception for me and allow me to make a purchase pre-release. I'm so anxious to finally please my wife and give her the satisfaction and pleasure I've been promising her for so long. Thank you. Best regards, Ulric Aristide
  - A: Ulric - See my reply via email I sent you.
- Q: Hello Mr. Bennett, First of all I'd like to congratulate you and the Morari team for accomplishing this great milestone of becoming FDA approved. So many men like myself will benefit from your product and will have a greater opportunity to please their wives and even potentially save their marriages. I invested over $1000 in the project as soon as I read about it a few years ago. And I've been waiting impatiently for it to finally be available for purchase. I have a very terrible case of premature ejaculation. I ejaculate with 15 to 20 seconds of sexual intercourse. This problem has had a serious strain on my marriage to the point that I always have to promise my wife that I will last a little longer in the second round. I can't wait to finally see the day when my wife climaxes before me. And I know that your product will be the reason for me attaining this great achievement.  You may not remember, but I previously wrote to you requesting to be one of your testers of the product. I was hoping that at least the beta version would help me last a little longer. Unfortunately, you didn't need any more testers. Now that the product has been FDA approved and I'm assuming it's in the process of mass production, I was wondering if you could do me a huge favor and allow me to purchase the product early before it is officially made accessible to the public. I'm not sure how long it will take to get to the market but I'm just so anxious to try it out. I've been waiting so long for it and I check my email every month for any updates. That's why I had to write to you after you sent out the good news yesterday. The fact that it's now FDA approved means that all possible concerns could now be put to rest. Using the product now will be the same as using it when it's made available to the public.  If you could please send me a link where I could pay the cost of the product and then ship it to me, I would be soooo grateful for this huge favor. I would be honored to be your first paid customer, who's also an investor in your vision and great effort of helping millions of men deal with and get over their problem of premature ejaculation. I pray that you make an exception for me and allow me to make a purchase pre-release. I'm so anxious to finally please my wife and give her the satisfaction and pleasure I've been promising her for so long. Thank you. Best regards, Ulric Aristide
  - A: Ulric - See my reply via email I sent you.
- Q: Are you planning to raise for more funds
  - A: Yes we do plan to raise additional funds. Stay tuned for more!
- Q: Hello Jeff, congrats on your progress so far. A couple of questions: 1) In the 12-31-2021 Morari Inc. Financial Statements document you say: "A total of $1,500,000 is needed by April 2023 to achieve regulatory clearance and begin selling online in early Q3, 2023". I would like to know if you are still on track for this with other funding sources as it does not look like the wefunder campaign achieved 1.5M? 2) The same statement sets the target date for FDA clearance for Q2 '23 – can you update us on progress? Has an application been filed? 3) When do you expect to launch and with what kind of volumes (update please)? 4) Your competitors at Virility have released a smart patch which has the same app-powered user experience as MOR. Also and additionally, they offer a simple ON-OFF patch without fiddly bluetooth which may be more desirable. Can you make an updated comment on the competitor landscape?
  - A: Enrico, We are still targeting a raise of $1.5M to achieve FDA clearance and launch readiness by the end of 2023. In addition to our Wefunder raise, we are pursuing several other sources for funding. We continue to make progress on our product to include design freeze. With design freeze, we are now moving into the formal testing phase which will gather the necessary data for regulatory submission. We expect to submit for regulatory clearance in late summer and have clearance by the end of the year. This plan and timing is contingent upon fundraising success. As needed, we will adjust our spending plan to focus on critical activities needed for regulatory clearance. Once launch ready, we will execute a 1,000 customer soft launch in a metropolitan market to gather user data, test messaging and refine logistics. We will also open the soft launch up to Wefunder investors. We will expand the launch to other markets once the soft launch has been completed. We are aware of Virility and congratulate them on their progress. As we understand it, the Virility product is only available in the UK right now. We have received the Virility product and have completed an assessment of it. The current version of the Virility product doesn't currently allow the user to change any settings. As each person responds to neurostimulation differently, the MOR product will give the user the ability to change settings and then save optimal settings for future events. The experience of determining optimal settings should be seen as a fun sexual experience for users. I hope this answers your questions. Feel free to reach out to me directly at jbennett@morarimedical.com to discuss further.
- Q: With the current raise, What will be your runway and when you need to raise again? Capital is drying in market.
  - A: We expect our current raise to give us 9 months of runway which will be followed by a series A raise of $3M.
- Q: Have you contacted a statistical study regarding the efficacy of the device? do you have any relevant results published in peer-reviewed literature?
  - A: At this time, we do not have any results published in peer-reviewed literature. We will gather post-market data and assess the need/interest to have published in peer-reviewed literature. During an institutional review board (IRB) approved feasibility study of our first generation prototype, all participating men reported a numeric increase in intravaginal ejaculation latency time (IELT) and on average was 45%. We believe our commercial product will perform better than this as our current prototype gives the user the ability to choose their own stimulation settings. We did not have this capability in the IRB study.
- Q: Given the recent events in the banking sector, please let us know what, if any, exposure you have to SVB (or SIVB), SBNY, SI, or FRC. Thanks
  - A: We have no exposure to SVBM, SBNY, SI or FRC as all of our banking is with JP Morgan Chase.
- Q: Please when is the campaign specifically ending??
  - A: We are planning to close the campaign on March 9. Let us know if you have any other questions.
- Q: Interesting product. Congrats on progress so far. I have a few questions: 1) Can you share who are current target customer segments and what are their drivers and willingness to pay of each segment?, 2) Beside the App, your product will consist of a reusable pulse generator and the single-use patches...How will you price these and what are the basis for pricing them in these particular ranges?, 3) can you provide a bit more detail that below on how you would differentiate yourself relative to current competition/next best alternatives including SSRI drugs, sprays/gels, etc. as and hardware providers such as Virility Medical as well as to potential future copy cats?
  - A: Hani - Anyone will be able to purchase the product, however, our market research has suggested that couples in committed relationships are a key customer segment to target initially. We call this segment "Performance Seekers". This segment has higher income, more open partners/more frequent sex, not explicitly dissatisfied with time to ejaculation and likely to have used other delay products. Our pricing is still TBD based on some additional pricing research we plan to complete. We have developed a chemical-free wearable patch that uses neurostimulation. Other PE products on the market are either drugs or chemical sprays/creams/wipes. Our research suggests that consumers would like another alternative to drugs or chemical sprays/creams/wipes if possible. We are aware of additional competitors and look forward to other companies helping to drive awareness of PE. We believe we will have an overall superior user experience that is protected by issued and filed patents.
- Q: Hi Jeff, looks like a great product and congrats on your success to date. I want to go back to the competition question posed by others. You've talked about alternative options, including the competition Virility. Assuming an "app controlled patch" is the preferred treatment method among men, what does the Mor patent protected to prevent knockoffs after your success? Or can a company, like Virility, do the same "app controlled patch" concept, but slightly different, and it becomes about speed to market and positioning as the market leader, like the Ring for home security cameras or Roomba for smart devices. Which leads to a follow-up question, since both got bought out by a larger player. Would you consider selling to a large company in 5-10 years or is your vision to grow this on your own as large as you can?
  - A: Great questions LD! We don't believe we can get a patent on neurostimulation to include app control as neurostimulation has been used for years safely and effectively all over the body for other treatments. A common neurostimulation application is transcutaneous electrical nerve stimulation (TENS). Our product is similar to a TENS unit but smaller and wireless. We do believe we can get a patent issued for how we deliver the neurostimulation and aspects of the product design. We have filed several patents around these areas. Our vision is to sell the company vs. grow it as large as we can. There are many global consumer goods and/or technology companies that have deep experience marketing and selling to consumers that may be able to benefit in additional growth from the emerging sexual health and wellness market.
- Q: What do you envisage your main sales channels to be? What will the product be priced at and what are your gross margins on the devices and on the patches?
  - A: Once FDA clearance has been achieved and product inventory in place, we will sell the product directly to consumers via a new dedicated online website. To execute this, we will initially use an existing e-commerce platform to take and fulfill orders. We will execute a soft launch for a period of 3 months before expanding to other markets. This soft launch approach will allow us to ensure that all aspects of the launch to include receiving orders, fulfillment and shipping are working as expected. In addition, the soft launch will allow us to gather important data related to order trends, customer profile and product performance. As awareness and sales for the Morari patch grows, we expect that large consumer goods retailers will be interested in offering the product via their channels. Market research conducted by Morari suggests that those affected by PE would be willing to pay a premium price for an effective treatment solution. To quote one of our online survey respondents: “It would help me save my relationship with the girl of my dreams. If your device works as expected, I would pay...a lot.” The first-generation product will include single-use patches and a reusable pulse generator. The initial pricing is pending further research. Prior to launch, we will conduct a formal pricing study which will be executed by experts in pricing research to ensure the appropriate pricing is being established. We will also evaluate a monthly subscription model as survey results suggested that 30% of potential customers said they would like to purchase via monthly subscription. Initial gross margins with be 60% or greater and trend higher at scale.
- Q: Your team seems to consist mainly of advisors. How many actual employees do you have today and how many do you envisage having in late 2023? What functions will they be performing?
  - A: Jeff Bennett is currently the only full-time employee. We have taken the approach of a contractor/consultant model until we are at the point of needing to add full-time employees. As our funding goals are achieved, we will add key leadership positions in commercialization, operations, R&D, finance, product management and social media.